Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2025.1734231 Correction Correction: Abemaciclib early access - an Italian experience CalabròConcetta 1 * Writing – review & editing Writing – original draft CannellaEleonora 2 Writing – original draft NardulliPatrizia 1 Writing – review & editing Struttura Complessa di Farmacia IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy Pharmacy Department, Provincial Health Authority of Syracuse, Syracuse, Italy Correspondence: Concetta Calabrò, concetta.calabro@oncologico.bari.it 11 11 2025 2025 15 1734231 28 10 2025 31 10 2025 Copyright © 2025 Calabrò, Cannella and Nardulli. 2025 Calabrò, Cannella and Nardulli https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Abemaciclib early access - an Italian experience By Calabrò C, Cannella E and Nardulli P (2025) Front. Oncol. 15:1563844. doi: 10.3389/fonc.2025.1563844 early access cost - saving breast cancer C(nn) category sustainability section-at-acceptance Breast Cancer

Affiliation “Struttura Complessa di Farmacia IRCCS Istituto Tumori “Giovanni Paolo II” Bari, Italy” was omitted for authors “Calabrò Concetta” and “Patrizia Nardulli”.

The Conflict of interest statement has been correct to “The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland